Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Päätekijät: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
1984
|
Samankaltaisia teoksia
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
Tekijä: Bowen, D, et al.
Julkaistu: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
Tekijä: Wilcock, G, et al.
Julkaistu: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
Tekijä: Emma Barrett, et al.
Julkaistu: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
Tekijä: Hunter White, et al.
Julkaistu: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
Tekijä: Marianna Yanike, et al.
Julkaistu: (2014-11-01)